JPWO2020216832A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020216832A5
JPWO2020216832A5 JP2021562783A JP2021562783A JPWO2020216832A5 JP WO2020216832 A5 JPWO2020216832 A5 JP WO2020216832A5 JP 2021562783 A JP2021562783 A JP 2021562783A JP 2021562783 A JP2021562783 A JP 2021562783A JP WO2020216832 A5 JPWO2020216832 A5 JP WO2020216832A5
Authority
JP
Japan
Prior art keywords
patient
determined
treatment
dhrs13
homer3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021562783A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022530390A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/061314 external-priority patent/WO2020216832A1/en
Publication of JP2022530390A publication Critical patent/JP2022530390A/ja
Publication of JPWO2020216832A5 publication Critical patent/JPWO2020216832A5/ja
Pending legal-status Critical Current

Links

JP2021562783A 2019-04-24 2020-04-23 抗精神病剤の応答を予測するための方法 Pending JP2022530390A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19305528 2019-04-24
EP19305528.2 2019-04-24
PCT/EP2020/061314 WO2020216832A1 (en) 2019-04-24 2020-04-23 Method for predicting the response of antipsychotic drugs

Publications (2)

Publication Number Publication Date
JP2022530390A JP2022530390A (ja) 2022-06-29
JPWO2020216832A5 true JPWO2020216832A5 (de) 2023-04-06

Family

ID=66439966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021562783A Pending JP2022530390A (ja) 2019-04-24 2020-04-23 抗精神病剤の応答を予測するための方法

Country Status (4)

Country Link
US (1) US20220290237A1 (de)
EP (1) EP3959340A1 (de)
JP (1) JP2022530390A (de)
WO (1) WO2020216832A1 (de)

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US69A (en) 1836-10-27 Machine eor picking or breaking wool and ginned or seedless cotton
US6927A (en) 1849-12-04 Improvement in pumps for raising water
US4888278A (en) 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US6280929B1 (en) 1986-01-16 2001-08-28 The Regents Of The University Of California Method of detecting genetic translocations identified with chromosomal abnormalities
US4774339A (en) 1987-08-10 1988-09-27 Molecular Probes, Inc. Chemically reactive dipyrrometheneboron difluoride dyes
US5132432A (en) 1989-09-22 1992-07-21 Molecular Probes, Inc. Chemically reactive pyrenyloxy sulfonic acid dyes
US5433896A (en) 1994-05-20 1995-07-18 Molecular Probes, Inc. Dibenzopyrrometheneboron difluoride dyes
US5274113A (en) 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5248782A (en) 1990-12-18 1993-09-28 Molecular Probes, Inc. Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
US5338854A (en) 1991-02-13 1994-08-16 Molecular Probes, Inc. Fluorescent fatty acids derived from dipyrrometheneboron difluoride dyes
US5427932A (en) 1991-04-09 1995-06-27 Reagents Of The University Of California Repeat sequence chromosome specific nucleic acid probes and methods of preparing and using
US5187288A (en) 1991-05-22 1993-02-16 Molecular Probes, Inc. Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
US5262357A (en) 1991-11-22 1993-11-16 The Regents Of The University Of California Low temperature thin films formed from nanocrystal precursors
US5505928A (en) 1991-11-22 1996-04-09 The Regents Of University Of California Preparation of III-V semiconductor nanocrystals
US6048616A (en) 1993-04-21 2000-04-11 Philips Electronics N.A. Corp. Encapsulated quantum sized doped semiconductor particles and method of manufacturing same
US5472842A (en) 1993-10-06 1995-12-05 The Regents Of The University Of California Detection of amplified or deleted chromosomal regions
US5571018A (en) 1994-11-23 1996-11-05 Motorola, Inc. Arrangement for simulating indirect fire in combat training
US5690807A (en) 1995-08-03 1997-11-25 Massachusetts Institute Of Technology Method for producing semiconductor particles
US5800996A (en) 1996-05-03 1998-09-01 The Perkin Elmer Corporation Energy transfer dyes with enchanced fluorescence
US5696157A (en) 1996-11-15 1997-12-09 Molecular Probes, Inc. Sulfonated derivatives of 7-aminocoumarin
US5830912A (en) 1996-11-15 1998-11-03 Molecular Probes, Inc. Derivatives of 6,8-difluoro-7-hydroxycoumarin
US5866366A (en) 1997-07-01 1999-02-02 Smithkline Beecham Corporation gidB
US6130101A (en) 1997-09-23 2000-10-10 Molecular Probes, Inc. Sulfonated xanthene derivatives
US5990479A (en) 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6617583B1 (en) 1998-09-18 2003-09-09 Massachusetts Institute Of Technology Inventory control
US6114038A (en) 1998-11-10 2000-09-05 Biocrystal Ltd. Functionalized nanocrystals and their use in detection systems
US6855202B2 (en) 2001-11-30 2005-02-15 The Regents Of The University Of California Shaped nanocrystal particles and methods for making the same
JP2002544488A (ja) 1999-05-07 2002-12-24 クアンタム ドット コーポレイション 半導体ナノクリスタルを用いて分析物を検出する方法
US6306736B1 (en) 2000-02-04 2001-10-23 The Regents Of The University Of California Process for forming shaped group III-V semiconductor nanocrystals, and product formed using process
US6225198B1 (en) 2000-02-04 2001-05-01 The Regents Of The University Of California Process for forming shaped group II-VI semiconductor nanocrystals, and product formed using process
WO2001071044A1 (en) 2000-03-22 2001-09-27 Quantum Dot Corporation Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
EP1286705A2 (de) 2000-06-01 2003-03-05 The Board Of Regents Of Oklahoma State University Nanopartikel-biokonjugate wie radiopharmaca
AU2001279185B2 (en) 2000-08-04 2005-07-07 Molecular Probes, Inc. Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
US6942970B2 (en) 2000-09-14 2005-09-13 Zymed Laboratories, Inc. Identifying subjects suitable for topoisomerase II inhibitor treatment
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US20020083888A1 (en) 2000-12-28 2002-07-04 Zehnder Donald A. Flow synthesis of quantum dot nanocrystals
US6670113B2 (en) 2001-03-30 2003-12-30 Nanoprobes Enzymatic deposition and alteration of metals
US6709929B2 (en) 2001-06-25 2004-03-23 North Carolina State University Methods of forming nano-scale electronic and optoelectronic devices using non-photolithographically defined nano-channel templates
JP4567436B2 (ja) 2001-07-20 2010-10-20 ライフ テクノロジーズ コーポレーション 発光ナノ粒子およびそれらの調製方法
ES2364037T3 (es) * 2001-12-10 2011-08-23 Novartis Ag Métodos de tratamiento de psicosis y esquizofrenia basados en polimorfismos del gen del cntf.
US7642064B2 (en) 2003-06-24 2010-01-05 Ventana Medical Systems, Inc. Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
JP4648902B2 (ja) 2003-06-24 2011-03-09 ベンタナ・メデイカル・システムズ・インコーポレーテツド 免疫組織化学的エピトープおよび核酸配列のインサイチュ検出が向上するように酵素の触媒作用で金属を付着
EP1893241A2 (de) 2005-04-28 2008-03-05 Ventana Medical Systems, Inc. Mit antikörpern über einen peg-linker konjugierte fluoreszierende nanopartikel
EP3144675A1 (de) 2005-04-28 2017-03-22 Ventana Medical Systems, Inc. Enzyme konjugiert an antikörper über einen peg heterobifuktionslinker
CA2631005C (en) 2005-11-23 2017-02-28 Ventana Medical Systems, Inc. Molecular conjugate
US8871443B2 (en) * 2007-03-26 2014-10-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs
CN102137938B (zh) * 2008-07-04 2015-01-21 解码遗传学私营有限责任公司 预测精神分裂症的风险的拷贝数变异
US20120129835A1 (en) * 2010-11-16 2012-05-24 Salk Institute For Biological Studies Schizophrenia methods and compositions
EP2807275A1 (de) * 2012-01-24 2014-12-03 The United States of America, as represented by the Secretary, Department of Health and Human Services Schizophrenie-vermittelte isoform von knch2 und entwicklung antipsychotischer arzneimittel
CN103848810A (zh) 2012-11-30 2014-06-11 北京赛林泰医药技术有限公司 鲁顿酪氨酸激酶抑制剂
US20140274764A1 (en) * 2013-03-15 2014-09-18 Pathway Genomics Corporation Method and system to predict response to treatments for mental disorders
US20170253928A1 (en) * 2013-03-15 2017-09-07 Pathway Genomics Corporation Method and system to predict response to treatments for mental disorders
ES2562684B1 (es) * 2014-08-04 2017-02-06 Consejo Superior De Investigaciones Científicas (Csic) Método de monitorización de tratamiento antipsicótico
KR101725600B1 (ko) * 2014-12-02 2017-04-11 (의료)길의료재단 유전자 다형성을 이용한 항정신병약물에 대한 치료 반응 예측을 위한 정보를 제공하는 방법

Similar Documents

Publication Publication Date Title
Kahn On the origins of schizophrenia
Springelkamp et al. New insights into the genetics of primary open-angle glaucoma based on meta-analyses of intraocular pressure and optic disc characteristics
Desai et al. Elucidating asthma phenotypes and endotypes: progress towards personalized medicine
Greenberg et al. Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis
Russo et al. Shorter telomere length in schizophrenia: Evidence from a real-world population and meta-analysis of most recent literature
Durisko et al. Using evolutionary theory to guide mental health research
Wiers et al. Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: a preliminary study
Mattey et al. Independent association of rheumatoid factor and the HLA–DRB1 shared epitope with radiographic outcome in rheumatoid arthritis
US20160068906A1 (en) Method of screening newborns for gene variants
Ahram et al. Variants in nebulin (NEB) are linked to the development of familial primary angle closure glaucoma in Basset Hounds
Camporesi et al. Bioethics, genetics and sport
Funuyet-Salas et al. Psychological biomarkers and fibrosis: an innovative approach to non-alcoholic fatty liver disease
Hayashi et al. Impact of functional studies on exome sequence variant interpretation in early-onset cardiac conduction system diseases
Hawley et al. An assessment of the role of vinculin loss of function variants in inherited cardiomyopathy
Saadah et al. Identification of a rare Exon 19 skipping mutation in ALMS1 Gene in Alström syndrome patients from two unrelated Saudi families
Légaré et al. First trimester plasma MicroRNA levels predict risk of developing gestational diabetes mellitus
Ng-Cordell et al. Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study
Dohm-Hansen et al. The'middle-aging'brain
Sung et al. Assessment of damage in Korean patients with systemic lupus erythematosus.
Aydin et al. Validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index and pSkindex27 for use in childhood-onset systemic lupus erythematosus
JPWO2020216832A5 (de)
Stephen et al. Cortical atrophy and hypofibrinogenemia due to FGG and TBCD mutations in a single family: a case report
van Dongen et al. Association between the COMT Val158Met polymorphism and aggression in psychosis: Test of a moderated mediation model in a forensic inpatient sample.
Riddell et al. Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
Ramsey‐Goldman et al. A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus